 |
| Dr Karen Alt |
|
 |
| Dr Tiffany Khong |
|
 |
| Dr Ioanna Savvidou |
|
Congratulations to Drs Karen Alt, Tiffany Khong and Ioanna Savvidou who have won Faculty Platform Access Grant (PAG) funding in 2016 for their project titled, "Validation of a novel beta-catenin inhibitor in a myeloma-induced bone disease utilising molecular imaging platforms".
Multiple Myeloma (MM) is the second most common hematologic malignancy
accounting for 13% of hematologic cancers. Despite the introduction of
new therapeutic modalities, relapse is inevitable due to the emergence
of drug resistance. Thus, it is important to identify and validate new
therapeutic agents that target alternative pathways that contribute to
the pathogenesis and progression of MM. This new treatment approach will
be evaluated by using molecular imaging for monitoring anti-myeloma
therapeutic effect in vivo.
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.